Fracture risk in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra 223)

被引：0
|
作者：
Hijab, A. [1 ]
Tunariu, N. [2 ]
Tovey, H. [3 ]
Alonzi, R. [4 ]
Tree, A. [1 ]
Staffurth, J. [5 ]
Blackledge, M. [6 ]
Padhani, A. R. [7 ]
Stidwill, H. [1 ]
Finch, J. [4 ]
Chatfield, P. [3 ]
Perry, S. [3 ]
Koh, D-M. [2 ]
Hall, E. [3 ]
Parker, C. [1 ]
机构：
[1] Royal Marsden NHS Fdn Trust, Inst Canc Res, Acad Urol Unit, Sutton, Surrey, England
[2] Royal Marsden NHS Fdn Trust, Inst Canc Res, Radiol, Sutton, Surrey, England
[3] Royal Marsden NHS Fdn Trust, Inst Canc Res, Clin Trials Unit, Sutton, Surrey, England
[4] Mt Vernon Canc Ctr, Urooncol, London, England
[5] Velindre Canc Ctr, Radiotherapy, Cardiff, Wales
[6] Royal Marsden NHS Fdn Trust, Inst Canc Res, Radiotherapy & Imaging, Sutton, Surrey, England
[7] Mt Vernon Canc Ctr, Paul Strickland Scanner Ctr, Radiol, Northwood, Middx, England
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.931
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
672P
引用
收藏
页码：S539 / S539
页数：1
相关论文
共 50 条
  • [1] Fracture risk after radium-223 (Ra-223) in metastatic castration resistant prostate cancer (mCRPC).
    Alonzi, Roberto
    Parker, Chris C.
    Tunariu, Nina
    Koh, Dow-Mu
    Staffurth, John
    Blackledge, Matthew D.
    Padhani, Anwar R.
    Tree, Alison
    Stidwill, Helen
    Finch, Jessica
    Chatfield, Peter
    Perry, Sophie
    Tovey, Holly
    Hall, Emma
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Use of Radium-223 in Men With Metastatic Castration-Resistant Prostate Cancer
    Parker, Chris
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (11) : 723 - 725
  • [3] Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) sequentially treated with abiraterone acetate (AA) and radium-223 (RA223).
    Caffo, Orazio
    Frantellizzi, Viviana
    Tucci, Marcello
    Galli, Luca
    Monari, Fabio
    Baldari, Sergio
    Masini, Cristina
    Bortolus, Roberto
    Facchini, Gaetano
    Alongi, Pierpaolo
    Zichi, Clizia
    Biasco, Elisa
    Fanti, Stefano
    Pignata, Salvatore
    Filice, Angelina
    Borsatti, Eugenio
    Rossetti, Sabrina
    Spada, Massimiliano
    Cortesi, Enrico
    De Vincentis, Giuseppe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Prognostic factors that affect survival outcomes in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223
    Al-Ezzi, Esmail Mutahar
    Alqaisi, Husam
    Picardo, Sarah
    Iafolla, Marco
    Sridhar, Srikala S.
    Sacher, Adrian G.
    Fallah-Rad, Nazanin
    Catton, Charles
    Warde, Padraig
    Hamilton, Robert James
    Fleshner, Neil Eric
    Zlotta, Alexandre
    Hansen, Aaron Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [5] Clinical factors that are prognostic for survival outcomes in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223
    Al-Ezzi, E. M. M.
    Alqaisi, H. A.
    Iafolla, M.
    Sridhar, S.
    Sacher, A.
    Fallah-Rad, N.
    Jiang, D. M.
    Catton, C.
    Warde, P.
    Hamilton, R.
    Fleshner, N.
    Zlotta, A.
    Hansen, A.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S537 - S538
  • [6] Sarcopenia assessment in men with metastatic castration-resistant prostate cancer (mCRPC) undergoing radium 223 (Ra223) therapy
    Khan, M.
    Carvajal, J. Briones
    Parshad, S.
    Emmenegger, U.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S535 - S535
  • [7] Pain efficacy with radium-223 (Ra-223) in the REASSURE global, prospective, observational study of men with metastatic castration-resistant prostate cancer (mCRPC)
    Higano, C. S.
    Dizdarevic, S.
    Sundar, S.
    Agarwal, N.
    Essler, M.
    Song, D.
    George, S.
    Shore, N. D.
    Kurtinecz, M.
    Verholen, F.
    Sandstrom, P.
    Sartor, O.
    George, D. J.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S640 - S641
  • [8] Radium-223 In The Treatment Of Metastatic Castration-Resistant Prostate Cancer
    Vazzana, C.
    Morano, S.
    Di Lascio, A.
    Grana, C.
    Chinol, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S880 - S880
  • [9] RADIUM-223: TREATING METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    James, D.
    Hillery, R.
    Freeman, L.
    Kumari, A.
    Kearney, N.
    [J]. INTERNAL MEDICINE JOURNAL, 2016, 46 : 30 - 31
  • [10] Radium-223 (Ra-223) in asymptomatic metastatic castration-resistant prostate cancer (mCRPC) patients treated in an international early access program (iEAP).
    Heidenreich, Axel
    Gillessen, Silke
    Heinrich, Daniel
    Keizman, Daniel
    O'Sullivan, Joe M.
    Carles, Joan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345